.webp)
A vast amount of research is stalled in today's disjointed scientific environment. Not because there is a lack of ideas or talented researchers, but rather because obtaining funding, coordinating science and sharing results is difficult and inefficient.
Bio Protocol was founded to remove these bottlenecks, so that researchers can concentrate on the work that really counts: uncovering breakthroughs and expanding knowledge.
How Bio Supports Researchers
The Bio platform makes it easier for researchers to raise funds for their research, create value from that research, and capture and distribute that value via commercial successes.
Since its launch in 2023, projects have used Bio Protocol to raise $50M+ over ~200 completed deals.
What Bio provides:
- Blockchain logistics, so scientists can focus on science.
- User-friendly tools for tokenizing, funding and commercializing your research.
- Access to Bio’s global community of crypto investors, early-adopters and partners to fund and accelerate your research.
- Branding, content and design support to give your research a market-friendly approach.
- Legal incorporation and set-up for launching a tokenized research project compliantly.
- Social media advisory and content support to maximize your reach and leverage the fast-growing Decentralized Science (DeSci) movement.
There are two key vehicles that researchers in the Bio Network can leverage to fund and accelerate their science:
- Intellectual Property Tokens (IPTs); and
- BioAgents (Decentralized Scientific AI Agents).
Intellectual Property Tokens (IPTs)
IPTs are intellectual property tokens - they are a vehicle to fundraise for science, from the crypto markets, by enabling crowdfunding for early-stage scientific research. We take nascent ideas, tokenize them to fund their development, and enable funds raised to be exchanged into USD or any fiat currency to fund R&D operations.
IPTs are great for research that needs smaller pools of capital to generate results and de-risk the research thesis. Since the future value of the research is represented by the token, you can reward participation in the R&D flow using this token, thereby creating new incentive models for collaboration and participation.
People buy IP Tokens because they want to participate in the long term potential future of your research. Their token allocation lets them participate in the community supporting the research. These are not securities, IPT holders do not automatically receive profits or guaranteed revenue if the IP is commercialized.
We’ve funded over 60 research projects using this model from synthetic biology to longevity to cryogenics to genetics and beyond. Collectively these projects are worth $40m+, held by more than 60k unique wallets and have generated more than $1B in trading volume.
IPTs are funded in weeks, not months or years like government grants or pharma VC cycles. They allow researchers to secure funding from a worldwide pool of investors, bypassing traditional bureaucratic processes. They uniquely allow early-stage value creation in scientific research, by introducing new collaborative and transparent models for research funding.
BioAgents: Scientific AI Agents to Scale Your Research & Intelligence
Another vehicle researchers can use to raise funds and build community around their research is Bio’s Decentralized AI Agents known as BioAgents. Researchers use Bio’s AI Agent platform to transform large sets of research papers and data into a dynamic knowledge graph (an organized database). From there, Bio turns this knowledge graph into an AI agent - making its scientific knowledge queryable and interactive like a specialized ChatGPT terminal.
Key capabilities:
- Give 24/7 access to your world view. Researchers and students globally can efficiently interact with your ideas 24/7, spreading your work and developing an incentive-aligned community around your research.
- Lab assistant. Trained on your context to formulate intriguing new scientific hypotheses and recommend next steps in individual scientific programs.
- Identify promising research areas. It can hold more context and information together than any human, and connect to agents developed by other labs in different biomedical fields, to find new experiments and “blind spots” in your research domain.
Finally, Bio can launch the agent as a crypto token that the market can buy to support your lab and research.
Real-world Example:
Bio’s first AI scientist was developed in partnership with renowned longevity researcher Dr. Aubrey de Grey. Dr. de Grey's team has integrated the Aubrai AI agent into their workflow to provide research suggestions and minimize the risk of critical errors. Learn more from Dr. de Grey and his team in this live stream, or interact with the Aubrey agent directly by tagging @Aubrai_ on Twitter, or request Beta access to the researcher terminal.
Why Should Researchers Care
Bio's infrastructure has already been used to launch and grow dozens of promising research projects across life sciences and beyond, funding biotech innovations that pharma overlooks and bringing new drugs and therapeutics to life more transparently, efficiently and inclusively than traditional systems.
Coin Your Science on Bio
Are you a researcher ready to bring your next big idea to the world?
Apply to launch your project on Bio at bio.xyz/scientists
Additional Resources:
- Bio Protocol Documentation
- IP Token Documentation (Molecule)
- Bio Protocol Research Referral Program
- Bio Ecosystem Projects
- Bio Protocol Science Updates (October 2025)
